110 related articles for article (PubMed ID: 6312756)
1. Intravesical administration of misonidazole in bladder carcinoma.
Ghoneim MA; Shaaban AA; El-Merzabani MM; Awaad HK; El Gammal S
Acta Radiol Oncol; 1983; 22(3):177-81. PubMed ID: 6312756
[TBL] [Abstract][Full Text] [Related]
2. Systemic, bladder wall, and bladder tumor concentration of misonidazole following intravesical administration in the rat.
Fathi MA; Fisher GJ; Pageau R; Tahan TW; Nigam VN; Brailovsky CA; Elhilali MM
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1397-400. PubMed ID: 6885552
[TBL] [Abstract][Full Text] [Related]
3. The topical use of misonidazole in bladder cancer.
Awwad HK; Abd El Moneim H; Abd El Baki H; Omar S; El Merzabani M; Farag HI
Prog Clin Biol Res; 1983; 132D():305-16. PubMed ID: 6634802
[TBL] [Abstract][Full Text] [Related]
4. Penetration of misonidazole after intravesical administration in cases of carcinoma of the bilharzial bladder.
Awwad HK; el-Merzabani MM; Burgers MV
Br J Cancer Suppl; 1978 Jun; 3():297-8. PubMed ID: 277248
[TBL] [Abstract][Full Text] [Related]
5. Anal submucosal injection: a new route for drug administration in pelvic malignancies. Part I. Experimental study of misonidazole distribution in serum and tissues, with special reference to urinary bladder. Preliminary report.
Shafik A; el-Merzabani MM; el-Aaser AA; el-Desouky GH
Invest Radiol; 1986 Mar; 21(3):278-81. PubMed ID: 3957602
[TBL] [Abstract][Full Text] [Related]
6. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Asakawa H; Watarai J; Hoshino T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
[TBL] [Abstract][Full Text] [Related]
9. Interstitial misonidazole. A preliminary report on a new perspective in clinical radiation sensitization and hypoxic cell chemotherapy.
Sealy R; Korrubel J; Cridland S; Blekkenhorst G
Cancer; 1984 Oct; 54(8):1535-40. PubMed ID: 6478394
[TBL] [Abstract][Full Text] [Related]
10. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
[TBL] [Abstract][Full Text] [Related]
12. Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Cancer; ; . PubMed ID: 6269723
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
